Action of angiotensin on vascular adrenergic nerve endings: facilitation of norepinephrine release.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D003250:Constriction; D004285:Dogs; D005260:Female; D006614:Hindlimb; D007668:Kidney / Q000294:innervation / Q000502:physiology; D008297:Male; D009130:Muscle, Smooth / Q000502:physiology; D009411:Nerve Endings / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism*; D010525:Peripheral Nerves / Q000502:physiology; D013268:Stimulation, Chemical; D013564:Sympathetic Nervous System / Q000187:drug effects*; D014316:Tritium; D014666:Vasomotor System / Q000502:physiology*
D014316:Tritium; D000804:Angiotensin II; D009638:Norepinephrine